Research
Elusys Therapeutics, Inc. announced Wednesday that it delivered the first doses of its treatment for inhalational anthrax, ANTHIM (obiltoxaximab) Injection, to the U.S. Strategic National Stockpile (SNS).
The company is providing the treatment to the SNS, the U.S. government’s store of... Read More »
Two Ebola vaccine candidates pose no major safety concerns and can elicit immune responses by one month after initial vaccination, according to a randomized, placebo-controlled clinical trial conducted in Liberia
The clinical trial was coordinated by researchers with the Partnership for... Read More »
Looking to a drug already on the market for treating thrombocytopenia, the U.S. Department of Health and Human Services (HHS) has joined a private corporation in evaluating its use against radiation injuries.
The drug in question is approved for use to treat low blood platelet counts resulting... Read More »
A research team at the George Washington University (GW) School of Medicine and Health Sciences (SMHS) was recently awarded more than $2 million from Leidos Biomedical Research, Inc. to begin a Zika virus vaccine trial in Brazil.
Led by David Diemert and Jeffrey Bethony, both professors of... Read More »
In response to reports that more than 230 cases of plague have appeared in Madagascar since August, the World Health Organization (WHO) recently sent a shipment of 1,190,000 doses of antibiotics and released $1.5 million in emergency funds in order to mitigate the spread of the disease.
The... Read More »
Sanofi’s ACAM2000 and associated contracts are now in the possession of Emergent BioSolutions Inc, following payment of a $117.5 million acquisition.
In all, Emergent has gained control of the only smallpox vaccine approved by the U.S. Food and Drug Administration, a cGMP live viral... Read More »
The National Institute of Allergy and Infectious Diseases (NIAID) is urging the importance of preparedness when it comes to biomedical research in the face of major disease outbreaks and pandemics.
In an article published in The Journal of the American Medical Association by Anthony Fauci,... Read More »
Smiths Detection recently introduced the HI-SCAN 6040 CTiX checkpoint scanner, the first product to feature the company’s proprietary CT (Computed Tomography) scanning technology, which is designed to enhance checkpoint security and efficiency.
The new scanner, which is being launched at... Read More »
A next-generation Zika virus vaccine candidate was the first to safely elicit an immune response in humans, according to a recent study conducted by researchers at the Perelman School of Medicine at the University of Pennsylvania, the Wistar Institute, Inovio Pharmaceuticals, and GeneOne Life... Read More »
After evaluating 36 women and fetuses exposed to Zika from January 2016 to May, researchers at Children’s National Health System found that 89 percent of those infected were exposed through a mosquito bite and 48 percent of were also exposed through an infected sexual partner.
Roberta... Read More »
Maryland Lt. Gov. Boyd K. Rutherford visited Smiths Detections, Inc. (SDI) facility near Edgewood, Maryland this week where he was given a demonstration of technologies to detect and identify opioids to help protect first responders from exposure.
Smiths Detection develops and manufactures... Read More »
There is something to be said for adapting to modern technology, but the Los Alamos National Laboratory is taking that a step further – leveraging technology with a project that combines Brazilian social media and traditional clinical data to track the growth of infectious diseases.
Nick... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) and Applied Research Associates, Inc. recently partnered to advance the development of respirators that can be reused up to 100 times for use in public health emergencies.
Under the agreement, which spans 15 months for a total... Read More »
The U.S. Department of Health and Human Services (HHS) recently announced it will purchase a lyophilized, or freeze-dried, smallpox vaccine for use by women who are pregnant or nursing and for people of any age who have HIV or atopic dermatitis.
The vaccine, developed by Denmark-based... Read More »
A new initiative aiming to utilize the benefits of distributed energy resources (DERs), such as customer-produced solar energy for restoration and recovery purposes after severe storms, was recently launched by researchers at the Lawrence Livermore National Laboratory (LLNL).
Led by LLNL... Read More »
Testing for anthrax could soon become a lot quicker, as the U.S. Department of Health and Human Services has announced it is in the midst of researching a point-of-care diagnostic test that could determine infection within 15 minutes.
The test determines whether a patient has been infected with... Read More »
The Ebola virus uses the body’s natural defenses to speed the rate of infection and cause its lethal effects, according to a recent study conducted by researchers with the University of Texas Medical Branch at Galveston (UTMB).
The study was in collaboration with the University of Washington... Read More »
Antibodies taken from patients infected with dengue fever are effective in treating Zika virus infection in rodents, according to a recent study conducted by researchers from Imperial College London and the Washington University in St. Louis.
Found in multiple regions throughout the world,... Read More »
Soligenix Inc. announced this week it is the recipient of $700,000 in funding to support a research project grant for the University of Hawai’i at Manoa aimed at developing a thermostabilized Ebola vaccine.
Soligenix, a biopharmaceutical company that develops and commercializes products which... Read More »
The Defense Advanced Research Projects Agency (DARPA) recently issued a Request for Information (RFI) to identify new technological components to aid its Mobile Force Protection (MFP) program in detecting and neutralizing small unmanned air system (sUAS) technologies.
Rather than end-to-end... Read More »
Three-quarters of mainland U.S. counties are now environmentally suitable for disease-transmitting mosquitoes, according to an update of models by the Centers for Disease Control and Prevention (CDC).
Two mosquito species--aedes aegypti and aedes albopictus--can survive for at least part of the... Read More »
A recent study by a Northeastern University associate research scientist found that increased time spent outdoors correlated to a higher risk for Zika infection.
The researcher, Marco Ajelli, surveyed residents of the Miami-Dade area and found that while the majority of people spent less than... Read More »
Experts from the Oregon State University, the Oregon Health and Science University’s College of Pharmacy and the Oregon Health Authority say that communication breakdowns are among the leading potentials for infection outbreaks of drug-resistant bacteria.
Supported by a slew of organizations,... Read More »
The National Institute of Allergy and Infectious Diseases (NIAID) recently awarded a total of $11.5 million to a team of researchers from the Texas Biomedical Research Institute, the University of Notre Dame and the Center for Infectious Disease Research (CIDR) to examine how the gene of the... Read More »
Two genes called Fut9 and SLc35c1, which regulate the metabolism of a particular sugar in cells, are responsible for making ricin so lethal to humans, according to a recently conducted study by researchers from the Austrian Academy of Sciences’ Institute of Molecular Biotechnology (IMBA).
The... Read More »
Animals such as tayra, new world monkeys, sloths, porcupines, and coatis may be incubators for a parasite that causes Chagas disease, according to a recent study conducted by researchers from the University of California-Riverside (UCR).
Despite affecting approximately 8 million people... Read More »
A new public-private partnership between the federal government and Janssen Research & Development LLC seeks to jointly innovate new products in the constantly evolving battle against influenza.
The partnership will see the U.S. Department of Health and Human Services’ Office of the Assistant... Read More »
Battelle introduced a new version of its DroneDefender device, which is used to counter threats from Unmanned Aircraft Systems (UAS), at Air Force Association’s Air, Space & Cyber Conference’s Technology Symposium this week.
The DroneDefender V2, a handheld and man-portable device, disrupts... Read More »
The U.S. Government Accountability Office (GAO) recently conducted a study on the capabilities and challenges of medical device technologies in order to assess their abilities to rapidly diagnose infectious diseases.
As infectious diseases continue to pose a public health threat throughout the... Read More »
A new experimental vaccine immunized genetically-altered mice from the Leishmania parasite, according to a recent study conducted by researchers from the Georgia Institute of Technology (Georgia Tech).
With more than 30 different strains, Leishmania is classified at the world’s... Read More »
Rep. Dan Donovan (R-NY) announced this week that the U.S. House of Representatives advanced his amendment to restore funding to the National Urban Security Technology Laboratory (NUSTL).
NUSTL, which is located in New York City, researches, develops and assesses new technologies for use by law... Read More »
A new drug called AQ-13 was shown to be effective against non-severe cases of malaria, according to a recent study conducted by researchers at Tulane University.
Results of the study may prove to be significant as worldwide disease researchers are increasingly finding that the parasite... Read More »
An office of the U.S. Department of Health and Human Services (HHS) recently announced that it would provide up to $62 million over the next five years to Summit Therapeutics for the development of an antibiotic to combat Clostridium difficile infections (CDI).
The secondary infection can occur... Read More »
Customs and Border Protection (CBP) and the United States Postal Service (USPS) should assess whether the costs of the new Electronic Advance Data (EAD) program outweigh the benefits.
In 2014 and 2015, USPS and CPB launched two pilot programs at the New York International Service Center (ISC)... Read More »
Artemisinin, a Chinese medicine used to treat malaria that often faces issues with an unstable supply, can be rapidly produced at an industrial rate by genetically engineering moss, according to a recent study conducted by researchers from the Malaysian Ministry of Higher Education the University... Read More »
